Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias

Hypertension in Pregnancy

Volumn 20, Issue 1, 2001, Pages 35-44

  Kupferminc, M J ^a   Fait, G ^a   Many, A ^a   Lessing, J B ^a   Yair, D ^a   Bar Am, A ^a   Eldor, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Abruptio placentae; Inherited thrombophilia; Low molecular weight heparin; Preeclampsia; Pregnancy complications

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ENOXAPARIN; FOLIC ACID; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; BIRTH WEIGHT; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PROPHYLAXIS; SOLUTIO PLACENTAE; THROMBOPHILIA; TREATMENT OUTCOME;

ANTICOAGULANTS; BIRTH WEIGHT; FEASIBILITY STUDIES; FEMALE; GESTATIONAL AGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; THROMBOPHILIA;

EID: 0034912277     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-100104170     Document Type: Article

References (30)

1. Preeclampsia: An endothelial cell disorder
2. Placental pathologic features of preterm preeclampsia
3. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic features
4. Placenta previa and abruptio placentae
5. Lupus anticoagulants, anticardiolipin antibodies and fetal loss
6. Underlying disorders associated with severe early-onset preeclampsia
7. The factor V leiden mutation may predispose women to severe preeclampsia
8. Factor V leiden, C >T MTHFR polymorphism and genetic susceptibility to preeclampsia
9. Hyperhomocystinemia and protein S deficiency in complicated pregnancies
10. Increased frequency of genetic thrombophilias in women with complications of pregnancy
11. Low-dose aspirin to prevent preeclampsia in women at high risk
12. Low-dose aspirin for preeclampsia - The unresolved question
13. A standard of fetal growth for the United States of America
14. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein newborn with massive thrombosis
15. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
16. Genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
17. Prevention of preeclampsia with lowdose aspirin in healthy, nulliparous pregnant women
18. CLASP a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women
19. Inherited thrombophilia and pregnancy
20. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
21. A study of sixty pregnancies in patients with the antiphospholipid syndrome
22. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
23. Low-molecular-weight heparins and their use in obstetrics and gynecology
24. Low-molecular-weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies
25. Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
26. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy
27. Severe preeclampsia-eclampsia in young women: Subsequent pregnancy outcome and remote prognosis
28. On reducing the frequency of severe abruptio placentae
29. Small-for-gestational births in successive pregnancy outcome: Results from a longitudinal study of births in Norway
30. Recurrence of intrauterine growth retardation